Pharmaron Beijing (03759.HK) Announces Monthly Return for November 2025

Bulletin Express12-02

Pharmaron Beijing Co., Ltd. (03759.HK) disclosed its monthly return for equity securities as of November 30, 2025, reporting no changes to its issued shares and treasury shares during the month. Its authorized share capital remained RMB 1,778,195,525, comprising 301,537,125 H shares listed on the Stock Exchange of Hong Kong (par value RMB 1 each) and 1,476,658,400 A shares listed on the Shenzhen Stock Exchange (par value RMB 1 each).

Among these H shares, 294,273,825 are issued, while 7,263,300 are held in treasury under the 2025 H Share Award and Trust Scheme. Meanwhile, all 1,476,658,400 A shares are issued with none in treasury. Details regarding the 2021, 2022, and 2023 Restricted A Share Incentive Schemes, as well as the 2025 H Share Award and Trust Scheme, were also reaffirmed. The report confirms that no share issuances, transfers, or cancellations occurred within November 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181203113?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 16:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181203113","market":"us","top_or_hot":-1,"title":"Pharmaron Beijing (03759.HK) Announces Monthly Return for November 2025","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. (03759.HK) disclosed its monthly return for equity securities as of November 30, 2025, reporting no changes to its issued shares and treasury shares during the month. Its authorized share capital remained RMB 1,778,195,525, comprising 301,537,125 H shares listed on the Stock Exchange of Hong Kong (par value RMB 1 each) and 1,476,658,400 A shares listed on the Shenzhen Stock Exchange (par value RMB 1 each).</p>\n<p>Among these H shares, 294,273,825 are issued, while 7,263,300 are held in treasury under the 2025 H Share Award and Trust Scheme. Meanwhile, all 1,476,658,400 A shares are issued with none in treasury. Details regarding the 2021, 2022, and 2023 Restricted A Share Incentive Schemes, as well as the 2025 H Share Award and Trust Scheme, were also reaffirmed. The report confirms that no share issuances, transfers, or cancellations occurred within November 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing (03759.HK) Announces Monthly Return for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing (03759.HK) Announces Monthly Return for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-02 16:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (03759.HK) disclosed its monthly return for equity securities as of November 30, 2025, reporting no changes to its issued shares and treasury shares during the month. Its authorized share capital remained RMB 1,778,195,525, comprising 301,537,125 H shares listed on the Stock Exchange of Hong Kong (par value RMB 1 each) and 1,476,658,400 A shares listed on the Shenzhen Stock Exchange (par value RMB 1 each).</p>\n<p>Among these H shares, 294,273,825 are issued, while 7,263,300 are held in treasury under the 2025 H Share Award and Trust Scheme. Meanwhile, all 1,476,658,400 A shares are issued with none in treasury. Details regarding the 2021, 2022, and 2023 Restricted A Share Incentive Schemes, as well as the 2025 H Share Award and Trust Scheme, were also reaffirmed. The report confirms that no share issuances, transfers, or cancellations occurred within November 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1181203113","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181203113","pubTimestamp":1764665372,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. (03759.HK) disclosed its monthly return for equity securities as of November 30, 2025, reporting no changes to its issued shares and treasury shares during the month. Its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成北京(03759.HK)公布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (03759.HK) disclosed its monthly return for equity securities as of November 30, 2025, reporting no changes to its issued shares and treasury shares during the month. Its authorized share capital remained RMB 1,778,195,525, comprising 301,537,125 H shares listed on the Stock Exchange of Hong Kong (par value RMB 1 each) and 1,476,658,400 A shares listed on the Shenzhen Stock Exchange (par value RMB 1 each).\nAmong these H shares, 294,273,825 are issued, while 7,263,300 are held in treasury under the 2025 H Share Award and Trust Scheme. Meanwhile, all 1,476,658,400 A shares are issued with none in treasury. Details regarding the 2021, 2022, and 2023 Restricted A Share Incentive Schemes, as well as the 2025 H Share Award and Trust Scheme, were also reaffirmed. The report confirms that no share issuances, transfers, or cancellations occurred within November 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181203113","isCrawlerRequest":true}